PRL is not only elevated post-partum, but is elevated by other factors too. Besides a sex diff erence-PRL levels are roughly one-third higher in women than in men (New et al. 2004 )-factors such as pregnancy, primary hyperthyroidism, medications, tumour of the pituitary, stress, anxiety and pain are all related to increased PRL levels (Mah and Webster 2002) . Up to 10% of the population may have PRL levels above the normal range (Josimovich et al. 1987) . Furthermore, PRL serves multiple functions in the body other than lactation. For example, PRL impacts immune function, reproductive behaviour, sleep and the stress response (Freeman et al. 2000) .
Some research has found that PRL is associated with aggression in animals (Numan 1988 ) and hostility in humans (Fava et al. 1981; Fava et al. 1988; Mastrogiacomo et al. 1982; Kellner et al. 1984) . It has been suggested that underlying this association is an adaptive mechanism called ' maternal aggression ' ; the high levels of PRL normally seen in female mammals shortly aft er giving birth promote behaviour in the mother that is protective of the newborn (Numan 1988) .
Medical conditions and medication
PRL is a pituitary hormone, and hyperprolactinaemia -serum levels above 500 mIU/L -is the most common endocrine disorder of the hypothalamic -pituitary axis (Mah and Webster 2002) . Pituitary tumour, a micro-adenoma that secretes PRL, is the most common cause of hyperprolactinaemia once other causes (pregnancy, primary hypothyroidism and drugs) are excluded (Mah and Webster 2002) . PRL negatively regulates pituitary hormones implicated in gonadal function, thus hyperprolactinaemia is oft en associated with menstrual and fertility problems (Serri et al. 2003) . As dopamine is a major PRL inhibitory factor, medications that impact the hypothalamic dopamine system or pituitary dopamine receptors aff ect PRL levels (Mah and Webster 2002) . For example, tricyclic anti-depressants, opiates and other medications that aff ect central dopamine transmission in turn increase PRL levels (Mah and Webster 2002; Torre and Falorni 2007) . Some other medications are said to increase PRL level, for example, oral contraceptives (Torre and Falorni 2007) or secondgeneration anti-psychotics (Penzner et al. 2009 ), but the eff ects of these medications on PRL levels may be weak.
Life stress, anxiety and pain

Prolactin, pregnancy and hostility
Prolactin (PRL) receptors are seen mainly in the hypothalamus, where binding is especially high in females (Di Carlo et al. 1992) . It is well established that the hypothalamus is implicated in the control of aggression in humans (Siegel and Victoroff 2009) . Th erefore it is plausible that PRL could be associated with aggression, especially in women around the time of birth when PRL levels are naturally at their highest (Battin et al. 1985) . However, not all studies have found that PRL levels are related to hostility or aggression (e.g., Barry et al. 2014) . Th is might be due in part to the heterogeneity of participant characteristics across the various studies, as discussed below.
2 J. A. Barry et al. Furthermore, the onset of symptoms of hyperprolactinaemia may coincide with important life events (Nunes et al. 1980) . Th ere is evidence that stressful early life events are related to hyperprolactinaemia (Nunes et al. 1980) . However, the exact role of life events in the pathogenesis of hyperprolactinaemia remains unknown (Sonino et al. 2004) . Th e relationship may be complex; for example, although one study found that childhood stress was related to hyperprolactinaemia in adulthood, the onset of the condition did not coincide with important life events (Assies et al. 1992) .
Higher PRL levels have been associated with acute stress among healthy populations (Fava and Guaraldi 1987; Biondi and Picardi 1999) . It is also well established that PRL secretion is aff ected by stress (Freeman et al. 2000) , and PRL secretion increases in response to stress in both animals (Donner et al. 2007; Torner and Neumann 2002; Torner et al. 2004 ) and humans (Reavley et al. 1997; Sonino et al. 2004) . Anxiety is known to be related to increased PRL levels (Fava et al. 1981; Fava et al. 1988; Mastrogiacomo et al. 1982; Kellner et al. 1984; Reavley et al. 1997) . Among women who are seeking medical treatment, high anxiety has been related to high levels of PRL (Fava et al. 1988; Reavley et al. 1997) . Additionally, PRL is known to increase in response to pain, mediated by several neurological factors, notably dopamine levels (Ben-Jonathan and Hnasko 2001; Del Pozo and Brownell 1979) .
Animal studies have shown that PRL, released in response to stress (Torner et al. 2004) , decreases the stress response across a variety of dimensions (Donner et al. 2007; Torner and Neumann 2002) . PRL impacts the behavioural, neurological and endocrine stress responses, for example, by decreasing stress-induced adrenocorticotropic hormone release (Donner et al. 2007; Torner and Neumann 2002) .
Aggression and hostility
Research assessing PRL and aggression-related emotions generally tends to focus on hostility, rather than anger or aggression. Although anger, aggression and hostility are all similar negative emotional states and may be used interchangeably in everyday conversation, these three constructs can be distinguished from each another. Miller et al. (Miller et al. 1996) defi ne anger as an unpleasant emotion which may be experienced cognitively and/ or physiologically; aggression is an overt behaviour, which may be expressed verbally or physically; and hostility is a negative cognitive state, involving beliefs and attitudes about other people, characterised by mistrust, cynicism and suspicion of others. Also, a distinction is oft en made between transient states of anger and enduring trait of hostility. While state anger is evident at a particular time, trait hostility is a more enduring characteristic. It is also possible that acute levels of state anger may increase PRL levels, and the experience of a chronic stressor -such as an illness -may lead to chronic increases in PRL. High levels of hostility are furthermore related to poor physical health, especially coronary heart disease (Miller et al. 1996) . In a meta-analysis assessing hostility and physical health, Miller and colleagues (Miller et al. 1996) found hostility to be an independent risk factor for coronary heart disease.
Comparability of assays over time
When comparing PRL levels over time, as in the present study where PRL samples spanning three decades are compared, it should be noted that there have been three separate International Reference Preparations (IRPs) between 1978 and 1988, each requiring a review of reference ranges for PRL (Schulster et al. 1989 ). Th us, the IRPs have changed from the fi rst review in 1978 (IRP 75/504), the second in 1986 (IRP 83/562) to the third in 1988 (IRP 84/500). Th e assignment of unitage to the second and third IRPs has been carefully calibrated to ensure that continuity from the fi rst IRP would be maintained. Th erefore, the longitudinal application of the reference range over time can be considered robust, provided that assay kit manufacturers have appropriately recalibrated their assay against the relevant contemporary IRP.
Th e stability of an assay over time will also depend on other factors such as continuity of antibody, which could reduce comparability of observed values across time. However, it would be reasonable to compare broad categories of measurement over time, for example, if a value is categorised as below the norm in the 1980s then it would be reasonable to infer that it would be categorised below the norm today.
Hypothesis
Given the existing evidence on this topic, it was hypothesised that published research would fi nd higher hostility ratings in women with elevated PRL levels.
Methods
Sources
Th is review followed the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines for systematic reviews of observational studies (Stroup and Berlin 2000) . A protocol for the review has been registered in PROSPERO (Centre for Reviews and Dissemination registration number: CRD42012002527).
Literature search
Articles in any language measuring hostility or aggression and PRL, which were listed in PubMed and MEDLINE published up to 2nd July 2012, and EMBASE from 1980 to 2nd July 2012, were identifi ed. Th e Cochrane Review Database was also searched up to 2nd July 2012. Th e keyword search term pairs ' prolactin ' and ' aggression ' , ' prolactin ' and ' hostil * ' , ' prolactin ' and ' anger ' , and ' prolactin ' and ' angry ' were entered simultaneously. Th e PubMed searches produced 209 articles for aggression, 65 for hostil * , 21 for anger and 24 for angry. A MEDLINE search from 1946 did not fi nd any articles in addition to those cited in PubMed. Th e EMBASE searches produced 322 articles for aggression, 80 for hostil * , 43 for anger and 5 for angry. Th e ' related article ' function was used to widen the results. Th e Cochrane Review Database did not produce any published reviews on PRL and aggression, hostility or anger. No further articles were produced by a hand search of relevant articles referenced in these publications. A study relevant to this topic conducted by the present authors (Barry et al. 2014) was included. Qualifi ed librarians assisted when articles were diffi cult to access.
Study selection
Each article was assessed by EM or JB, and articles that fi tted the main criteria (measuring PRL and aggression, hostility or anger) were accessed. When it was unclear whether an article met the inclusion criteria, an attempt was made to contact the authors. For example, the standard deviation (SD) scores for hostility in one of the studies (Gro ë r 2005) were not presented in the published article, but an email was sent to the lead author who subsequently supplied this information. Although some studies did not report PRL values, but rather referred to groups as having ' high ' or ' low ' PRL levels, such studies were included as their exclusion would have limited the number of articles included in this review. Age was reported in the selected studies, but was not a factor that could be controlled for using meta-analysis because the original studies did not report outcomes by age group.
Methodological quality was independently assessed by JB and EM based on the criteria of the Newcastle -Ottawa Quality Assessment Scale (NOS) for case -control studies (Wells et al. 2000) adapted for observational studies and for the present study. In order for the methodological quality to be relevant to the present study rather than to a generalised notion of observational studies (Stang 2010) , several adaptations to the criteria were made. For example, ' ascertainment of exposure ' was changed to ' ascertainment of diagnosis ' , and studies of hospitalised patients that used other patients as controls were considered of higher quality than those that used healthy women as a control group. Other changes to the NOS criteria are listed in Table I .
Inclusion and exclusion criteria
Studies were included if they had the following features:
Participants were mentally healthy women, indicated by the a) absence of a psychiatric diagnosis. Participants were grouped based on naturally occurring (rather b) than experimentally induced) PRL level, and hostility was the dependent (or outcome) variable. Hostility was measured as a quantitative outcome using a c) validated questionnaire scale or subscale. Hostility and PRL were reported in units of means and SDs, d)
or were presented clearly in graphic form (e.g., a line graph with error bars, in which means and SDs could be clearly identifi ed). Th e studies reported other relevant data, for example, particie) pant age, numbers of participants per group, etc.
Studies were excluded if they
Had mixed groups of men and women; a)
Participants were children or adolescents -these were excluded b)
because PRL is known to act diff erently in children than in adults; Data duplicated previously published fi ndings. c)
Articles with titles or abstracts that indicated that they were not relevant (e.g., reviews, single-case studies, etc.) were excluded.
Statistical analysis
Statistical analyses were performed using Review Manager, Version 5.1. Groups of studies were meta-analysed using the inverse variance method, with a random-eff ects model, where there was signifi cant heterogeneity. Heterogeneity was assessed using I 2 and chi-square statistics. An I 2 value of 30% was considered the threshold for moderate heterogeneity, and a chi-square p value Ͻ 0.10 was considered the threshold for signifi cant heterogeneity. Th us, analyses showing I 2 values Ͼ 30% and chi-square p values Ͻ 0.10 could be analysed using a random-eff ects model, and heterogeneity below the thresholds Case defi nition adequate: description of PRL levels in high PRL group and how levels were measured from at least one source (medical records, etc.). Representativeness of cases: either random sample from complete sampling frame, or consecutive cases. Selection of controls: for the purposes of this meta-analysis, a star is given for a patient control rather than community control. Defi nition of controls: PRL levels measured in controls to assess their levels. Comparability of both groups: give a star for any of the following: anxiety, life stress, psychiatric medication and pain. Ascertainment of PRL levels: method of assay described for high PRL and patient controls. Same ascertainment method for all groups: method of assay is similar in high PRL and patient controls.
could be analysed using a fi xed-eff ects model. Th e eff ect size was measured as the standard mean diff erence, calculated using Hedges ' g . Like Cohen ' s d , a Hedges ' g of 0.2 can be considered a small diff erence; 0.5, a moderate diff erence; and 0.8 or more, a large diff erence between groups. Note that these eff ect size values indicate statistical eff ect size rather than clinical eff ect size.
Results
Studies of PRL and aggression, hostility or anger ( n ϭ 1065) were retrieved. Of these, 632 were duplicates, and of the remaining 433, a further 426 studies did not meet the inclusion criteria, leaving a total of 7 studies. One article (Barry et al. 2014 ) was unpublished at the time but met the inclusion criteria, so was included. Eight studies with a total of 576 participants (242 women with high PRL, 207 patient controls and 127 healthy controls) qualifi ed for review according to the inclusion criteria. Th e patient control groups (as opposed to healthy control groups) in these studies consisted of women with a variety of conditions (e.g., galactorrhoea, menstrual dysfunction, infertility, pituitary abnormalities, micro-adenoma, uraemic women on dialysis and caesarean section) as well as women in the immediate post-partum period being visited in their homes by researchers, and women attending a family practice. Not all of them were hospitalised patients or had an illness (e.g., the post-partum group), but all were under some type of medical supervision so the term ' patient ' was applied to all, albeit somewhat loosely. Regarding raw data from studies, Moss et al. (1990) did not report means and SDs in a table, but Figure 1 of their article clearly depicts this information. Regarding duplication of previous published fi ndings: although fi ndings from the patient control group of Mastrogiacomo et al. (1982) were original and unpublished, two of the groups (high PRL and healthy controls) duplicated data published by Fava et al. (1981) . Th us a comparison of the latter two groups was excluded from the present meta-analysis in order to avoid duplication of analyses. Table I shows the characteristics of the included studies. Table II shows the methodological quality of the included studies, based on adapted NOS criteria. Th ere was generally good agreement between the raters regarding NOS scoring, and any scoring not agreed upon was discussed and resolved.
Main outcomes
Figures 1, 2 and 3 show forest plots and test statistics for the comparisons. Based on heterogeneity scores, outcome variables were meta-analysed using random-eff ects models. Table III summarises the results of the meta-analyses. Table III shows that there were non-signifi cantly higher hostility levels in the women with high PRL compared with those in patient controls ( Z ϭ 1.45, p Ͻ 0.15; Hedges ' g ϭ 0.38; 95% CI: Ϫ 0.13 -0.89). Th ere was signifi cantly higher hostility in the high PRL group compared with that in healthy control women ( Z ϭ 1.94, p Ͻ 0.05; Hedges ' g ϭ 0.72; 95% CI: Ϫ 0.01 -1.45), and signifi cantly higher hostility in patient controls compared with that in healthy controls ( Z ϭ 1.94, p Ͻ 0.05; Hedges ' g ϭ 0.47; 95% CI: 0.00 -0.94). Th ere was considerable heterogeneity in the fi ndings of these studies, with I 2 values ranging from 57% to 86%. Th e J Obstet Gynaecol Downloaded from informahealthcare.com by University College London on 06/11/15
For personal use only. confi dence intervals crossed zero in two of the three subgroup analyses. Tables IV and V show the mean (SD) PRL and hostility scores in the groups. Figure 4a shows the funnel plot for the studies comparing hostility in women with high PRL compared with patient controls, and Figure 4b shows the funnel plot for the studies comparing hostility in women with high PRL compared with that in healthy controls. Both Figure 4a and b show asymmetric funnel plots, with the smaller studies from the 1980s (cluster of studies at lower right of graphs) showing the largest eff ect sizes, whereas the larger studies from the 1990s onwards (clustered in upper middle/left ) show more conservative fi ndings (smaller Hedges ' g ). However, the clustering is weaker in 4(a), and perhaps not much regarding publication bias can be concluded from these funnel plots given the considerable heterogeneity in the fi ndings (Terrin et al. 2003) . Th e funnel plot for the comparison between patient controls and healthy controls is almost identical to that in Figure 4b . It can be interpreted in the same way as Figure 4b , and is not shown here in order to conserve space. 
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Discussion
Th is meta-analysis assessed studies that compared levels of hostility in women with diff erent levels of PRL. It was found that women with high PRL levels report more hostility than women with normal PRL levels. However, the apparent eff ect of PRL on hostility was reduced almost by half when patient controls were used as the comparator instead of healthy controls. In statistical terms, the Hedges ' g was reduced from a moderate-to-large eff ect size (Hedges ' g ϭ 0.72) to a moderate-to-small eff ect size (Hedges ' g ϭ 0.38) when controlling for patient status. Th us, roughly half of the hostility seen in the high PRL groups can be accounted for by the fact that participants are women with health issues rather than women who are healthy. Th e remaining eff ect size not explained by patient status (a Hedges ' g of 0.34) may be attributable to PRL, or perhaps to a combination of PRL and other unknown factors. However, the fact that the confi dence intervals crossed zero in both of these subgroup analyses and the substantial heterogeneity in the fi ndings indicates that confi dence in the validity of these fi ndings should be tempered with caution. On the other hand, the fi nding of signifi cantly higher hostility in the patient control group Figure 4 . Figure a shows the funnel plot for the studies comparing hostility in women with high PRL compared with patient controls, and Figure b shows the funnel plot for the studies comparing hostility in women with high PRL compared with that in healthy controls. compared with that in the non-patient control group (a Hedges ' g of 0.47) supports the suggestion that patient status explains at least a small-to-moderate (a Hedges ' g of between 0.34 and 0.47) amount of the hostility seen in this meta-analysis. Although there was a substantial amount of heterogeneity (I 2 ϭ 57%), the confidence intervals did not cross zero, thus lending some statistical validity to the fi nding of this subgroup analysis. Sometimes heterogeneity can be accounted for by diff erences in the methodology employed in the studies, and the heterogeneity seen in the fi ndings of the present study may be an example of this. In general, the methodological quality of the included studies was acceptable (a median NOS score of fi ve out of nine). One study (Uvn ä s-Mobcrg et al. 1990) scored only two NOS stars, mainly because there were no patient controls and the healthy controls from a population norm. More importantly, an inspection of the characteristics of the eight studies highlights several ways in which they diff ered from one another. Th ese diff erences were seen in fi ve areas: (1) studies varied in the range of PRL levels included in their comparisons; (2) half of the studies used the same measure of hostility (the Kellner Symptom Questionnaire [KSQ] ), but the others used various other measures of hostility; (3) half of the studies used exactly the same assay method, but the other studies used slightly diff erent assays; (4) half of the studies had small sample sizes ( N Ͻ 50); and (5) the characteristics of the women in the high PRL groups varied across studies. Closer inspection, in the following paragraphs, of the details of these differences will allow some sense of the degree to which these diff erences may infl uence how the fi ndings can be interpreted.
Studies varied in the range of PRL levels used in their comparisons, and varied in how these levels were identifi ed. It is possible that the eff ect of PRL on hostility is only seen when the levels are above the norm, yet not all studies included women with PRL levels verifi ably above the norm. Th is could explain why some studies, which did not assess abnormally high PRL, did not fi nd a relationship between PRL and hostility. Furthermore, most studies included at least one group in which PRL levels are inferred rather than measured. For example, Table V shows that, for the high PRL group, two studies did not provide any information on the PRL levels (Uvn ä s- Mobcrg et al. 1990 ; Gro ë r 2005). PRL levels were not measured in three of the six patient control groups, and were not measured in fi ve of the six studies that used healthy controls, but were simply presumed to be normal. Also, in one study only a minority of the high PRL group had levels above the normal range (Barry et al. 2014) . Th e uncertainty introduced by this disparity in defi nition of the groups may have contributed to the heterogeneity in the fi ndings, though contrary to this suggestion, the removal of the Barry et al. ' data in fact slightly increases the I 2 value. Apart from the issue of heterogeneity in the present meta-analysis, accurately measuring and verifying all of the participants ' PRL levels increases the clinical and scientifi c value of a study. Nevertheless, despite the lack of uniformity across these studies, they still off er valuable insights. Th e studies of high PRL due to medical conditions (Kellner et al. 1984; Fava et al. 1981; Fava et al. 1988 ) are of importance to our understanding of the psychopathology of PRL, and the studies of PRL values within the normal range (Barry et al. 2014) or in post-partum women (Gro ë r 2005; Uvn ä s- Mobcrg et al. 1990; Mastrogiacomo et al. 1982) are of importance to our understanding of the normal psychobiology of PRL. Future studies need to measure PRL values in all participants and allocate them to their corresponding groups. Furthermore, future research relating PRL to hostility in women while hospital patients compared to when they are healthy again would be of value as this would further elucidate the impact of patient status on the relationship between these variables.
Diff erent types of hostility questionnaire were used; four of the studies were consistent in the way they measured hostility, all using the KSQ (Kellner et al. 1984; Mastrogiacomo et al. 1982; Fava et al. 1981; Fava et al. 1988) . Although the items in the KSQ are not dissimilar to items from other hostility questionnaires, it may be that this measure is particularly sensitive to the relationship between PRL and hostility. Table V shows that the scores were within the known norms for all groups, whichever questionnaire was used (apart from the questionnaire used in one study for which a norm is not known (Gro ë r 2005) ). Future studies of PRL and hostility should consider using the KSQ because it has proved to yield consistent fi ndings in this fi eld.
Ideally, every study would use the same type of assay for PRL. Some consistency was evident in the included studies, in that three of the studies (Kellner et al. 1984; Mastrogiacomo et al. 1982; Fava et al. 1981; Fava et al. 1988 ) used the same assay method (a radioimmunoassay [RIA] kit from Biodata, Italy). (One of the four studies from this group of authors, [Kellner et al. 1984] did not state the assay used). Th e other studies used assays from other manufacturers, but it is unlikely that diff erences in the assay manufacturer or method will have contributed to the heterogeneity seen in the meta-analysis. Nevertheless, future studies are best advised to use the gold standard assay method.
Four studies that found the largest eff ect had small samples, that is, sample sizes below 50 (Fava et al. 1981; Fava et al. 1988; Mastrogiacomo et al. 1982; Kellner et al. 1984) , and the four studies that found weak or no eff ects had sample sizes over 50 (Reavley et al. 1997 ; Gro ë r 2005; Uvn ä s- Mobcrg et al. 1990) . Th is might suggest that the apparent eff ect of PRL on hostility may in part be due to ' small studies eff ects ' , and this would imply ungeneralisable fi ndings due to selection bias. However, the small studies were relatively heterogeneous within their methodology and fi ndings; we might conclude that it would be valid to generalise their fi ndings to populations of women similar to those participating in those studies. Nonetheless, future studies should be guided by a formal sample size calculation and, as a general rule, recruit sample sizes of fi ft y at a minimum. Also, a future meta-analysis on this topic will be improved by an increased overall sample size.
Characteristics of the women in the high PRL groups varied across studies. It is noteworthy that the meta-analysis found that the diff erence in hostility levels in the three groups (high PRL, patient controls and healthy controls) is explained to some degree by whether the participants were under some kind of medical care or whether they were healthy. Table I shows that the characteristics of the participants in the high PRL groups in the diff erent studies vary by more than just PRL; most women in the high PRL groups had medical conditions, whereas two of the high PRL groups were of healthy post-partum women (Gro ë r 2005; Uvn ä s- Mobcrg et al. 1990 ). Indeed, a potential confounder of this study is that the control groups contained patients with conditions that might refl ect abnormalities in the pituitary -gonadal axis. Table I shows that, for example, control groups contained women with polycystic ovary syndrome, normoprolactinaemic pituitary disease and subfertility. Although each of these control groups can be justifi ed to some extent, the heterogeneity of conditions is not ideal in comparative studies. It is notable that the eff ect of PRL on hostility was generally seen most clearly in former rather than the latter type of group. In fact, the removal of the two studies of post-partum women from the comparison of high PRL to healthy controls improves the I 2 value from 86% to 0%, which narrows down the source of heterogeneity considerably, at least for the comparison of high PRL patients to healthy controls. On the other hand, removing the post-partum studies from the comparison of high PRL with patient controls and patient controls with healthy controls changes the I 2 value, but only modestly, from 81% to 76% and increases from 57% to 69%, respectively. Th e role of patient status in the relationship between PRL and hostility is particularly interesting, given the relationship between stress and PRL: stress induces PRL release (in animal models) and subsequently diminishes the stress response (Donner et al. 2007; Torner et al. 2004) . It is, therefore, essential that future research adequately control for the impact of stress, particularly the stress related to patient status.
Future studies might also consider measuring neuroticism in addition to hostility, as scores on the two measures may be correlated (Felsten 1996) . A relationship between hostility and PRL may also be found between neuroticism and PRL, suggesting that susceptibility to stress may be the underlying cause of a relationship among PRL, hostility and neuroticism.
Any one of fi ve factors described above may have increased the heterogeneity, but their combination probably makes heterogeneity diffi cult to avoid. However, it appears that one source of heterogeneity comes from the inclusion of the post-partum studies, at least for the comparison of high PRL to healthy controls, indicating that these studies may best be considered separately from studies of patients with medical conditions. In any case, some degree of heterogeneity is oft en seen in meta-analyses, and does not usually invalidate fi ndings regarding the main outcomes of interest. Th us, the fi ndings regarding the impact of PRL and patient status on hostility should be accepted, but with appropriate caveats regarding the type of patient population being assessed.
A potential limitation of this meta-analysis is that some of the included studies did not control for age or disease type. However, levels of PRL are relatively stable in women during their reproductive years, and because none of the studies that reported age compared premenopausal women with post-menopausal women, it remains uncertain whether age was a confounding variable in those studies. Also, not all of the studies controlled for disease 8 J. A. Barry et al. type, that is, some studies did not compare identical disease types in high and low PRL groups, meaning that we cannot be sure if the fi ndings in these studies were related to diff erences in disease type rather than PRL. In general, the studies would have been improved by using an anxiety measure as a covariate to measure changes in PRL related to the stress of having a disease.
It is interesting to consider how the fi ndings might relate to the everyday clinical care of patients. Th e fi ndings from the comparison of patients with normal PRL to healthy controls might lead one to the conclusion that people who are under medical care may be more hostile than healthy people. It is known that pain, stress and medication may increase PRL levels (Torre and Falorni 2007; Biondi and Picardi 1999; Del Pozo and Brownell 1979) . It is also known that the type of pain experienced by a patient infl uences how much these negative feelings are felt and expressed (Pilowsky and Spence 1976) . Research by Folkman & Lazarus (Folkman and Lazarus 1980) suggests that hostility and aggression are characteristics of a confrontive coping style . Confrontive coping is described by Guthrie and Nayak (Guthrie and Nayak 2012) as one of the coping styles used by people in reaction to their physical illness. Hospitalised patients using this method of coping might present as being aggressive in help-seeking behaviour and hostile in relation to health professionals. Perhaps, it might be useful for such a patient to learn more acceptable coping strategies or relaxation training. From the point of view of everyday patient care, it may be preferable to treat hostility at a psychological level rather than a hormonal level.
Although one in four people with physical illness go on to develop a mental illness due to the stress of the physical illness (Guthrie and Nayak 2012) , there is relatively little research into how the stress of having a medical condition, or being in medical care, contributes to a patient ' s feelings of hostility. Future studies might explore this important issue further because it has a bearing on patient care, the doctor -patient relationship and the working environment of all those in contact with distressed patients. We might infer that because in many cases the source of a patient ' s hostility is related to their physical discomfort rather than dissatisfaction with their care, it is probably important for health professionals to not blame patients for hostility or to not take hostility from patients personally.
In conclusion, this meta-analysis suggests that PRL may be associated with a female patient ' s level of hostility. It also appears that the various stressors that are part of being under medical care may increase PRL and hostility in patients. Further high-quality, well-controlled research is required in order to identify defi nitively the precise magnitude of the eff ect of PRL on hostility.
